Company Karolinska Development AB
Equities
KDEV
SE0002190926
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 SEK | 0.00% | +4.25% | -7.54% |
04-26 | Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election | CI |
Business Summary
Number of employees: 8
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -12.43% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -12.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 06/12/15 |
Director of Finance/CFO | 56 | 30/09/22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/05/20 |
Chief Investment Officer | 58 | 28/02/21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 30/04/20 |
Corporate Officer/Principal | 59 | 31/10/15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 31/12/06 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Cochlovius
CHM | Chairman | 56 | 31/12/19 |
Viktor Drvota
CEO | Chief Executive Officer | 59 | 06/12/15 |
Director/Board Member | 55 | 18/02/21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 18/02/21 |
Theresa Tse
BRD | Director/Board Member | 32 | 27/11/17 |
Philip Duong
BRD | Director/Board Member | 34 | 11/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 2,555,261 | 0 | 0 | 35.96 % |
Stock B | 1 | 267,522,333 | 97,108,178 ( 36.30 %) | 244,285 ( 0.0913 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
OSSDSIGN AB 9.83% | 9,596,662 | 9.83% | 9,064,815 $ |
Company contact information
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 52 48 60 70
http://www.karolinskadevelopment.comGroup companies
Name | Category and Sector |
---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.54% | 38.64M | |
-2.17% | 187B | |
-1.77% | 106B | |
-3.96% | 66.9B | |
-0.15% | 49.45B | |
+16.43% | 48B | |
+4.06% | 40.84B | |
+3.44% | 26.48B | |
+1.19% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- KDEV Stock
- Company Karolinska Development AB